Erratum: Lack of platelet-activating factor receptor protects mice against diet-induced adipose inflammation and insulin-resistance despite fat pad expansion (Obesity (2014) 22 (663-672) DOI: 10.1002/oby.20142);Lack of platelet-activating factor receptor protects mice against diet-induced adipose inflammation and insulin-resistance despite fat pad expansion

Obesity

Volumn 22, Issue 3, 2014, Pages 663-672

  Menezes Garcia, Zélia ^a   Oliveira, Marina C ^a   Lima, Renata L ^a   Soriani, Frederico M ^a   Cisalpino, Daniel ^a   Botion, Leida M ^a   Teixeira, Mauro M ^a   Souza, Danielle G ^a   Ferreira, Adaliene V M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RANTES; RESISTIN; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; CYTOKINE RELEASE; EPIDIDYMIS FAT; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOGENESIS; LIPOLYSIS; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; WEIGHT GAIN;

MUS;

ADIPOCYTES; ADIPOSE TISSUE; ADIPOSITY; ANIMALS; DIET; DIETARY CARBOHYDRATES; GLUCOSE INTOLERANCE; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; LIPOGENESIS; LIPOLYSIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLATELET MEMBRANE GLYCOPROTEINS; PPAR GAMMA; RECEPTORS, G-PROTEIN-COUPLED; RESISTIN; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT GAIN;

EID: 84895824459     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20767     Document Type: Erratum

References (38)

1. Hotamisligil GS,. Inflammation and metabolic disorders. Nature 2006; 44: 860-867.
2. Hotamisligil GS, Shargill NS, Spiegelman BM,. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
3. Pini M, Rhodes DH, Fantuzzi G,. Hematological and acute-phase responses to diet-induced obesity in IL-6 KO mice. Cytokine 2011; 56: 708-716.
4. McGillicuddy FC, Harford KA, Reynolds CM, et al. Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis. Diabetes 2011; 60: 1688-1698.
5. Wu H, Ghosh S, Perrard XD, et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007; 115: 1029-1038.
6. Gregor MF, Hotamisligil GS,. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011; 29: 415-445.
7. Ryden M, Arner P,. Fat loss in cachexia-is there a role for adipocyte lipolysis? Clin Nutr 2007; 26: 1-6.
8. Dourado LP, Noviello MD, Alvarenga DM, et al. Experimental food allergy leads to adipose tissue inflammation, systemic metabolic alterations and weight loss in mice. Cell Immunol 2011; 270: 198-206.
9. Mehta NN, McGillicuddy FC, Anderson PD, et al. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 2010; 59: 172-181.
10. Dahlman I, Mejhert N, Linder K, et al. Adipose tissue pathways involved in weight loss of cancer cachexia. Br J Cancer 2010; 102: 1541-1548.
11. Spencer SJ, Tilbrook A,. The glucocorticoid contribution to obesity. Stress 2011; 14: 233-246.
12. Boon Yin K, Najimudin N, Muhammad TS,. The PPARgamma coding region and its role in visceral obesity. Biochem Biophys Res Commun 2008; 371: 177-179.
13. Ishii S, Kuwaki T, Nagase T, et al. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med 1998; 187: 1779-1788.
14. Souza DG, Fagundes CT, Sousa LP, et al. Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection. Proc Natl Acad Sci USA 2009; 33: 14138-14143.
15. Soares PM, Lima-Junior RC, Mota JM, et al. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Cancer Chemother Pharmacol 2010; 68: 713-720.
16. Triggiani M, Schleimer RP, Warner JA, Chilton FH,. Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. J Immunol 1991; 146: 660-666.
17. Gountopoulou A, Leondaritis G, Galanopoulou D, Mavri-Vavayanni M,. TNFα is a potent inducer of platelet-activating factor synthesis in adipocytes but not in preadipocytes. Differential regulation by PI3K. Cytokine 2008; 41: 174-181.
18. Ye RD, Prossnitz ER, Zou AH, Cochrane CG,. Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem Biophys Res Commun 1991; 180: 105-111.
19. Montrucchio G, Alloatti G, Camussi G,. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 2000; 80: 1669-1699.
20. Yost CC, Weyrich AS, Zimmerman GA,. The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. Biochimie 2010; 92: 692-697.
21. Hasegawa S, Kohro Y, Shiratori M, et al. Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain. PLoS One 2010; 5: e10467.
22. Snyder F,. Metabolic processing of PAF. Clin Rev Allergy 1994; 12: 309-327.
23. Wymann MP, Schneiter R,. Lipid signalling in disease. Nat Rev Mol Cell Biol 2008; 9: 162-176.
24. Kudolo GB, Bressler P, DeFronzo RA,. Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment. J Lipid Mediat Cell Signal 1997; 17: 97-113.
25. Wegner M, Araszkiewicz A, Pioruńska-Mikołajczak A, Zozulińska-Ziõłkiewicz D, Wierusz-Wysocka B, Pioruńska-Stolzmann M,. The evaluation of IL-12 concentration, PAF-AH, and PLA(2) activity in patients with type 1 diabetes treated with intensive insulin therapy. Clin Biochem 2009; 42: 1621-1627.
26. Derbent A, Kargili A, Koca C, et al. Serum platelet-activating factor acetylhydrolase activity: relationship with metabolic syndrome in women with history of gestational diabetes mellitus. Gynecol Endocrinol 2011; 27: 128-133.
27. Garcia CC, Russo RC, Guabiraba R, et al. Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in mice. PLoS Pathog 2010; 6: e1001171.
28. Kosteli A, Sugaru E, Haemmerle G, et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest 2010; 120: 3466-3479.
29. Wallenius V, Wallenius K, Ahrén B, et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002; 8: 75-79.
30. García MC, Wernstedt I, Berndtsson A, et al. Mature-onset obesity in interleukin-1 receptor I knockout mice. Diabetes 2006; 55: 1205-1213.
31. Spite M, Hellmann J, Tang Y, et al. Deficiency of the leukotriene B4 receptor, BLT-1, protects against systemic insulin resistance in diet-induced obesity. J Immunol 2011; 187: 1942-1949.
32. Green A, Dobias SB, Walters DJ, Brasier AR,. Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipase. Endocrinology 1994; 134: 2581-2588.
33. Wootton PT, Flavell DM, Montgomery HE, World M, Humphries SE, Talmud PJ,. Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise training. Nutr Metab Cardiovasc Dis 2007; 17: 24-31.
34. Botion LM, Brasier AR, Tian B, Udupi V, Green A,. Inhibition of proteasome activity blocks the ability of TNF alpha to down-regulate G(i) proteins and stimulate lipolysis. Endocrinology 2001; 142: 5069-5075.
35. Guilherme A, Virbasius JV, Puri V, Czech MP,. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9: 367-377.
36. Gasic S, Green A,. Gi down-regulation and heterologous desensitization in adipocytes after treatment with the alpha 2-agonist UK 14304. Biochem Pharmacol 1995; 49: 785-790.
37. Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006; 116: 1494-1505.
38. Tzotzas T, Filippatos TD, Triantos A, Bruckert E, Tselepis AD, Kiortsis DN,. Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women. Nutr Metab Cardiovasc Dis 2008; 18: 477-482.